Literature DB >> 19091948

Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein.

Dengshun Miao1, Hanyi Su, Bin He, Jianjun Gao, Qingwen Xia, Min Zhu, Zhen Gu, David Goltzman, Andrew C Karaplis.   

Abstract

Parathyroid hormone (PTH) plays a central role in the regulation of serum calcium and phosphorus homeostasis, while parathyroid hormone-related protein (PTHrP) has important developmental roles. Both peptides signal through the same G protein-coupled receptor, the PTH/PTHrP or PTH type 1 receptor (PTH1R). PTHrP, normally a secreted protein, also contains a nuclear localization signal (NLS) that in vitro imparts functionality to the protein at the level of the nucleus. We investigated this functionality in vivo by introducing a premature termination codon in Pthrp in ES cells and generating mice that express PTHrP (1-84), a truncated form of the protein that is missing the NLS and the C-terminal region of the protein but can still signal through its cell surface receptor. Mice homozygous for the knock-in mutation (Pthrp KI) displayed retarded growth, early senescence, and malnutrition leading postnatally to their rapid demise. Decreased cellular proliferative capacity and increased apoptosis in multiple tissues including bone and bone marrow cells were associated with altered expression and subcellular distribution of the senescence-associated tumor suppressor proteins p16(INK4a) and p21 and the oncogenes Cyclin D, pRb, and Bmi-1. These findings provide in vivo experimental proof that substantiates the biologic relevance of the NLS and C-terminal portion of PTHrP, a polypeptide ligand that signals mainly via a cell surface G protein-coupled receptor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091948      PMCID: PMC2629292          DOI: 10.1073/pnas.0805690105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues.

Authors:  P H Watson; L J Fraher; G N Hendy; U I Chung; M Kisiel; B V Natale; A B Hodsman
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

Review 2.  The multifunctional nucleolus.

Authors:  François-Michel Boisvert; Silvana van Koningsbruggen; Joaquín Navascués; Angus I Lamond
Journal:  Nat Rev Mol Cell Biol       Date:  2007-07       Impact factor: 94.444

3.  Premature aging in mice activates a systemic metabolic response involving autophagy induction.

Authors:  Guillermo Mariño; Alejandro P Ugalde; Natalia Salvador-Montoliu; Ignacio Varela; Pedro M Quirós; Juan Cadiñanos; Ingrid van der Pluijm; José M P Freije; Carlos López-Otín
Journal:  Hum Mol Genet       Date:  2008-04-28       Impact factor: 6.150

4.  Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.

Authors:  Nathalie Fiaschi-Taesch; Brian M Sicari; Kiran Ubriani; Todd Bigatel; Karen K Takane; Irene Cozar-Castellano; Alessandro Bisello; Brian Law; Andrew F Stewart
Journal:  Circ Res       Date:  2006-10-05       Impact factor: 17.367

5.  Parathyroid hormone hormone-related protein and the PTH receptor regulate angiogenesis of the skin.

Authors:  A Godwin Diamond; Ryan M Gonterman; Aileen L Anderson; Keshav Menon; Carlos D Offutt; Chad H Weaver; William M Philbrick; John Foley
Journal:  J Invest Dermatol       Date:  2006-05-04       Impact factor: 8.551

6.  Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor.

Authors:  Thomas Dean; Jean-Pierre Vilardaga; John T Potts; Thomas J Gardella
Journal:  Mol Endocrinol       Date:  2007-09-13

Review 7.  Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.

Authors:  Robert L Jilka
Journal:  Bone       Date:  2007-04-06       Impact factor: 4.398

8.  Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis.

Authors:  Kathy Lee; Gautam Adhikary; Sivaprakasam Balasubramanian; Ramamurthy Gopalakrishnan; Thomas McCormick; Goberdhan P Dimri; Richard L Eckert; Ellen A Rorke
Journal:  J Invest Dermatol       Date:  2007-07-12       Impact factor: 8.551

9.  Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.

Authors:  Nabanita S Datta; Glenda J Pettway; Chen Chen; Amy J Koh; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2007-07       Impact factor: 6.741

10.  Adaptive stress response in segmental progeria resembles long-lived dwarfism and calorie restriction in mice.

Authors:  Marieke van de Ven; Jaan-Olle Andressoo; Valerie B Holcomb; Marieke von Lindern; Willeke M C Jong; Chris I De Zeeuw; Yousin Suh; Paul Hasty; Jan H J Hoeijmakers; Gijsbertus T J van der Horst; James R Mitchell
Journal:  PLoS Genet       Date:  2006-10-02       Impact factor: 5.917

View more
  40 in total

1.  PTHrP 1-141 and 1-86 increase in vitro bone formation.

Authors:  Blake Eason Hildreth; Jillian L Werbeck; Nandu K Thudi; Xiyun Deng; Thomas J Rosol; Ramiro E Toribio
Journal:  J Surg Res       Date:  2010-03-16       Impact factor: 2.192

2.  Deletion and point mutations of PTHLH cause brachydactyly type E.

Authors:  Eva Klopocki; Bianca P Hennig; Katarina Dathe; Randi Koll; Thomy de Ravel; Emiel Baten; Eveline Blom; Yves Gillerot; Johannes F W Weigel; Gabriele Krüger; Olaf Hiort; Petra Seemann; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2010-02-18       Impact factor: 11.025

3.  PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target.

Authors:  Jiarong Li; Andrew C Karaplis; Dao C Huang; Peter M Siegel; Anne Camirand; Xian Fang Yang; William J Muller; Richard Kremer
Journal:  J Clin Invest       Date:  2011-11-07       Impact factor: 14.808

4.  The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice.

Authors:  Ramiro E Toribio; Holly A Brown; Chad M Novince; Brandlyn Marlow; Krista Hernon; Lisa G Lanigan; Blake E Hildreth; Jillian L Werbeck; Sherry T Shu; Gwendolen Lorch; Michelle Carlton; John Foley; Prosper Boyaka; Laurie K McCauley; Thomas J Rosol
Journal:  FASEB J       Date:  2010-02-09       Impact factor: 5.191

5.  The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low-turnover osteopaenia.

Authors:  D Lozano; L Fernández-de-Castro; S Portal-Núñez; A López-Herradón; S Dapía; E Gómez-Barrena; P Esbrit
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

6.  Systemic and acute administration of parathyroid hormone-related peptide(1-36) stimulates endogenous beta cell proliferation while preserving function in adult mice.

Authors:  K Williams; D Abanquah; S Joshi-Gokhale; A Otero; H Lin; N K Guthalu; X Zhang; A Mozar; A Bisello; A F Stewart; A Garcia-Ocaña; R C Vasavada
Journal:  Diabetologia       Date:  2011-07-29       Impact factor: 10.122

7.  Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates.

Authors:  Teresa Anne Mills; Marlana Orloff; Marina Domingo-Vidal; Paolo Cotzia; Ruth C Birbe; Rossitza Draganova-Tacheva; Maria P Martinez Cantarin; Madalina Tuluc; Ubaldo Martinez-Outschoorn
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

Review 8.  Parathyroid hormone-related protein: an update.

Authors:  John J Wysolmerski
Journal:  J Clin Endocrinol Metab       Date:  2012-06-28       Impact factor: 5.958

9.  Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survival.

Authors:  V Bhatia; M K Saini; M Falzon
Journal:  Regul Pept       Date:  2009-07-17

Review 10.  PTH receptor-1 signalling-mechanistic insights and therapeutic prospects.

Authors:  Ross W Cheloha; Samuel H Gellman; Jean-Pierre Vilardaga; Thomas J Gardella
Journal:  Nat Rev Endocrinol       Date:  2015-08-25       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.